Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Congenital Abnormalities × Sorafenib × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 49 Carcinoma, Renal Cell 23 Liver Neoplasms 22 Neoplasms 18 Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Kidney Neoplasms 10 Leukemia, Myeloid, Acute 9 Melanoma 8 Sarcoma 7 Prostatic Neoplasms 7 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Ovarian Neoplasms 5 Brain Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Pancreatic Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leiomyosarcoma 3 Gliosarcoma 3 Gallbladder Neoplasms 3 Carcinoma 3

Interventions

fludarabine phosphate 32 Cytarabine 29 Cyclophosphamide 24 Whole-Body Irradiation 23 Peripheral Blood Stem Cell Transplantation 23 Mycophenolic Acid 22 Busulfan 21 Tacrolimus 19 Cyclosporine 15 Filgrastim 14 Etoposide 14 Antilymphocyte Serum 14 Methotrexate 13 Melphalan 11 Idarubicin 9 Granulocyte Colony-Stimulating Factor 9 Clofarabine 8 Mitoxantrone 7 Flow Cytometry 7 Sirolimus 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 aldesleukin 5 Vorinostat 5 Daunorubicin 5 thymoglobulin 4 fludarabine 4 alvocidib 4 Thiotepa 4 Polymerase Chain Reaction 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡